Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,797 | Dovepress* | 7,180+ | 1,472 | 8,652 | |
| PubMed Central* | 617 | 272 | 889 | ||
| Totals | 7,797 | 1,744 | 9,541 | ||
| *Since 18 January 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 2 | 2 |
View citations on PubMed Central and Google Scholar